Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | W Harb J Abramson M Lunning A Goy K Maddocks C Lebedinsky A Senderowicz P Trojer W D Bradley I Flinn | ||||||||||||
Title | A phase 1 study of CPI-1205, a small molecule inhibitor of EZH2, preliminary safety in patients with B-cell lymphomas | ||||||||||||
|
|||||||||||||
URL | https://academic.oup.com/annonc/article/29/suppl_3/mdy048.001/4917513 | ||||||||||||
Abstract Text | Annals of Oncology, Volume 29, Issue suppl_3, 1 March 2018, abstract 420 |
Molecular Profile | Treatment Approach |
---|
Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
---|
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|
Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|